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- Investigate the cleavage properties of trypsin after a
citrulline residue.
- Investigate the behavior of citrullinated peptides by
reversed phase chromatography.
- Propose a verification strategy for detected citrullinated 
peptides in a MS workflow.
24 synthetic peptide sets containing either arginine or citrulline were 
analyzed (JPT Peptide Technologies GmbH). The peptide sequences 
originated from disease-associated in vivo citrullinated proteins. 
In-solution tryptic digestion was performed with sequencing grade 
trypsin (Promega). 1 pmol sample was analysed using ESI 
LC-MS/MS in positive ion mode, on a hybrid microQTOF mass 
spectrometer (Bruker). The peptides were seperated using an 
in-house packed 10 cm reversed phase C18 column (Dr. Maisch; 
reprosil-pur C18-AQ) with acetonitrile.
Extracted ion chromatograms (XIC) were constructed in Bruker 
Daltonics DataAnalysis v 3.4, with all predicted tryptic peptides 
+/- m/z 0.01, under the assumption that trypsin cleaves after ar-
ginine, lysine and citrulline.
- Our results clearly demonstrate the inability of trypsin to 
cleave after citrulline residues. As a result, a miscleavage can 
be used to distinguish a citrullination from a deamidation of 
asparagine or glutamine.
- The shift in retention time was, for 22 of 24 peptides large 




















In situ digestion results were compared to 
the empirical data. For SP 10, prior to 
digestion only the synthetic peptide is 
detected and after digestion, peptides 
corresponding to PAPDR, LLLASPR and 
SCYK are detected, corresponding to a 
successful complete cleavage after 495Arg. 
This is not the case after digestion of SP 
10Cit, where peptides corresponding to 
PAPDR and LLLASPCitSCYK are detected. 
All investigated peptides demonstrate this 
behavior.
.
Our results clearly demonstrate the in-
ability of trypsin to cleave after citrul-
line residues. Hence, a miscleavage in-
dicates the presence of the PTM. Fur-
thermore, the shift in retention time 
between the citrulline and arginine 
peptides was large enough for 22 of 
the 24 peptides to ensure that coelu-
sion is not occurring to a detectable 
extend,  ensuring that both peptides 
can be identified.
Citrullination is a PAD-enzyme catalyzed 
deimination of arginine, yielding the 
non-standard amino acid citrulline.1
Protein citrullination has been associated with 
several diseases and auto-antibodies against 
citrullinated proteins are today used as an 
important clinical biomarker in rheumatoid 
arthritis.2,7 The site-specific characterization of 
citrullination using mass spectrometry remains 
problematic, especially as citrullination and 
deamidation of asparagine or glutamine results 
in the same mass increase of +0.984016 Da. 
The verification, therefore, often relies on a 
tryptic miscleavage after citrulline.3 
Furthermore, the mass increase is close to that 
of a neutron, +1.08665 Da.
However, tryptic cleavage after citrulline has in 
some cases been reported, so we here 
investigate the cleavage properties of trypsin 
after a citrulline residue.
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1 DS R/Cit GNPTVEVDLFTSKGLFR P06733.2 2.4 
2 DPS R/Cit YISPDQLADLYKSFIK P06733.2 3.0 
3 EELGSKAKFAG R/Cit NF R/Cit NPLAK P06733.2 1.6 
4 VTTSTRTYSLGSAL R/Cit PSTSR AAH66956 1.4 
5 EQLKGQGKS R/Cit LGDLYEEEMR AAH66956 2.6 
6 NMKEEMARHL R/Cit EYQDLLNVK AAH66956 1.4 
7 NMKEEMA R/Cit HLREYQDLLNVK AAH66956 2.0 
8 LHVA R/Cit SEMDKV R/Cit VFQAT R/Cit GK NP_036519.2 3.6 
9 GLKEFPIK R/Cit VMGPDFGYVTR NP_036519 3.4 
10 PAPDRKGFRLLLASP R/Cit SCYK NP_036519 2.0 
11 LS R/Cit TVRCTCISISNQPVNPR P02778.2 1.6 
12 EMHGKNWSKLC R/Cit DCQVIDGR ACB10579 1.6 
13 SGVTKAISSPTVS R/Cit LTDTTK ACB10579 1.4 
14 AEGGGV R/Cit GPRVVE R/Cit HQSACK P02671 0 
15 SHHPGIAEFPS R/Cit GKSSSYSK P02671 0.4 
16 FTSSTSYN R/Cit GDSTFESKSYK P02671 1.0 
17 A R/Cit HGFLP R/Cit HRDTGILDSIGR P02686.3 2.6 
18 LSRFSWGAEGQ R/Cit PGFGYGGR P02686.3 2.0 
19 PGFGYGG R/Cit ASDYKSAHKGFK P02686.3 0.6 
20 LSKIFKLGG R/Cit DSRSGSPMAR P02686.3 0.6 
21 Y R/Cit VYCDMNTENGGWTVIQNR P02675 0 
22 MYLIQPDSSVKPY R/Cit VYCDMR P02675 3.4 
23 EAPSL R/Cit PAPPPISGGGYRAR P02675 2.0 
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